Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticles
Open Access

Prognostic Significance of EZH2-Related Gene Variants in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy

SHU-PIN HUANG, BO-YING BAO, TA-HSIEN CHUANG, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, TE-LING LU and YEI-TSUNG CHEN
Cancer Genomics & Proteomics July 2025, 22 (4) 611-623; DOI: https://doi.org/10.21873/cgp.20525
SHU-PIN HUANG
1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;
2Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.;
3Institute of Medical Science and Technology, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BO-YING BAO
4Department of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TA-HSIEN CHUANG
4Department of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHAO-YUAN HUANG
5Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIA-CHENG YU
6Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.;
7Department of Urology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.;
8Department of Pharmacy, College of Pharmacy and Health Care, Tajen University, Pingtung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VICTOR C. LIN
9Department of Urology, E-Da Hospital, Kaohsiung, Taiwan, R.O.C.;
10School of Medicine for International Students, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TE-LING LU
4Department of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YEI-TSUNG CHEN
11Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yeitsungchen{at}nycu.edu.tw
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 22 no. 4 611-623
DOI 
https://doi.org/10.21873/cgp.20525
PMID 
40571313

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received February 26, 2025
  • Revision received April 28, 2025
  • Accepted May 5, 2025
  • Published online June 26, 2025.

Copyright & License 
Copyright © 2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. SHU-PIN HUANG1,2,3,*,
  2. BO-YING BAO4,*,
  3. TA-HSIEN CHUANG4,
  4. CHAO-YUAN HUANG5,
  5. CHIA-CHENG YU6,7,8,
  6. VICTOR C. LIN9,10,
  7. TE-LING LU4 and
  8. YEI-TSUNG CHEN11⇑
  1. 1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;
  2. 2Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.;
  3. 3Institute of Medical Science and Technology, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan, R.O.C.;
  4. 4Department of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.;
  5. 5Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan, R.O.C.;
  6. 6Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.;
  7. 7Department of Urology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.;
  8. 8Department of Pharmacy, College of Pharmacy and Health Care, Tajen University, Pingtung, Taiwan, R.O.C.;
  9. 9Department of Urology, E-Da Hospital, Kaohsiung, Taiwan, R.O.C.;
  10. 10School of Medicine for International Students, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
  11. 11Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
  1. Yei-Tsung Chen, Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, 155 Linong Street Section 2, Taipei 112, Taiwan, R.O.C. Tel: +886 228267000 ext. 66249, e-mail: yeitsungchen{at}nycu.edu.tw
  1. ↵* These Authors contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 2 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 22 (4)
Cancer Genomics & Proteomics
Vol. 22, Issue 4
July-August 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Significance of EZH2-Related Gene Variants in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Significance of EZH2-Related Gene Variants in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
SHU-PIN HUANG, BO-YING BAO, TA-HSIEN CHUANG, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, TE-LING LU, YEI-TSUNG CHEN
Cancer Genomics & Proteomics Jul 2025, 22 (4) 611-623; DOI: 10.21873/cgp.20525

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Significance of EZH2-Related Gene Variants in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
SHU-PIN HUANG, BO-YING BAO, TA-HSIEN CHUANG, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, TE-LING LU, YEI-TSUNG CHEN
Cancer Genomics & Proteomics Jul 2025, 22 (4) 611-623; DOI: 10.21873/cgp.20525
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Angiogenic Edge of ANGPT2: Genetic Variants Shape Prostate Cancer Prognosis on Androgen Deprivation Therapy
  • Google Scholar

More in this TOC Section

  • CRISPR/Cas9-mediated Knockout of LYVE1 In Human Tongue Cancer Cells Reveals Transcriptomic Changes in Metastasis-associated Pathways
  • Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility
  • CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms
Show more Articles

Keywords

  • prostate cancer
  • EZH2
  • epigenetic regulation
  • gene set enrichment analysis
  • survival
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire